Aplidin Studies - Aplidin Myeloma Studies - Studies on Aplidin

MULTIPLE MYELOMA KNOWLEDGE CENTER

How is Aplidin currently being studied in myeloma?

Aplidin studies evaluate the drug in combination with dexamethasone in a Phase III trial in relapsed/refractory myeloma that is being conducted in the United States, Europe, and Australia. A total of 250 patients will be enrolled in the study, called ADMYRE, and the combination will be compared to dexamethasone alone.